Carrie L. Bourdow

CIK 1638989 · Acting CEO · last filed 2024-10-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.1K

Companies

3

Total Filings

39

Lifetime Open-Market Net

$115.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRVN President & CEO 642,923 $0.01 $7.1K $117.9K 26 2023-12-15
Nabriva Therapeutics plc (NBRV) Delisted Director 9,933 $1.42 $14.1K -$2.4K 8 2022-08-03
Carisma Therapeutics Inc. (SESN) Delisted Director 40,000 $12.58 $503.0K $0 4 2022-06-24

Recent Filings · Page 4 of 4

39 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-03-02 TRVN Grant (A) $0 EDGAR
2017-09-19 Nabriva Therapeutics plc (NBRV) Delisted Grant (A) $0 EDGAR
2017-08-29 TRVN Grant (A) $0 EDGAR
2017-08-02 Nabriva Therapeutics plc (NBRV) Delisted Grant (A) $0 EDGAR
2017-03-03 TRVN Grant (A) $0 EDGAR
2017-01-06 TRVN Grant (A) $0 EDGAR
2016-11-10 TRVN Buy (P) +4,000 $17.4K EDGAR
2016-03-07 TRVN Grant (A) $0 EDGAR
2015-05-05 TRVN Grant (A) $0 EDGAR
Showing 3139 of 39
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.